Saladaga, Maribel T.

HRN: 24-13-74  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/27/2023
12/03/2023
IVTT
500mg
Q8h
Intestinal Amoebiasis With Moderate Dehydration
Waiting Final Action 
11/29/2023
METRONIDAZOLE 500MG (TAB)
11/29/2023
12/02/2023
PO
750mg
Q8h
AGE With Moderate Dehydration
Waiting Final Action 
11/29/2023
CIPROFLOXACIN 500MG (TAB)
11/29/2023
12/05/2023
PO
500mg
Q12
AGE With Moderate Dehydration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: